semaglutide linked to cancer Podcast: Is Ozempic (Semaglutide) Safe? Does It Increase Risk? GLP-1 Drugs and Cancer Risk

Theyre neither miracle drugs nor villains

Dose-response from STEP trials The STEP 5 trial (Garvey et al., Nat Med, 2022) demonstrated that semaglutide 2.4 mg produced 15.2% mean body weight reduction at 104 weeks

3Dosificacin, inicio del tratamiento y tcnica de administracin Escalada de dosis: formulacin subcutnea para control de peso (2,4 mg objetivo) Escalada de dosis: formulacin subcutnea para diabetes tipo 2 Escalada de dosis: formulacin oral para diabetes tipo 2 Instrucciones de administracin Formulacin subcutnea: inyeccin semanal en abdomen, muslo o parte superior del brazo

In that analysis, GLP-1 receptor agonists plus progestins were associated with a significantly lower risk of endometrial cancer than progestins alone, and the combination was also associated with fewer hysterectomies